Summary of Purpose
To assess the safety, clinical outcome, and adverse events in patients treated with intravenous tPA for acute stroke.Read More →
The following dates are available for this trial. Trial information last updated on 25 January 2001.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Prospective, multicenter study of 389 patients at 57 medical centers in the United States.
GW Albers, Stanford Stroke Center, Stanford University Medical Center, Palo Alto, California 94304-1705, USA.firstname.lastname@example.org